Mettler-Toledo International Future Growth
Future criteria checks 2/6
Mettler-Toledo International is forecast to grow earnings and revenue by 7.7% and 3.7% per annum respectively while EPS is expected to grow by 10.7% per annum.
Key information
7.7%
Earnings growth rate
10.7%
EPS growth rate
Life Sciences earnings growth | 21.6% |
Revenue growth rate | 3.7% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 22 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 4,220 | 996 | 985 | 1,057 | 6 |
12/31/2025 | 4,041 | 920 | 914 | 977 | 11 |
12/31/2024 | 3,829 | 833 | 865 | 942 | 11 |
12/31/2023 | 3,788 | 789 | 861 | 966 | N/A |
9/30/2023 | 3,911 | 870 | 883 | 988 | N/A |
6/30/2023 | 3,954 | 889 | 858 | 969 | N/A |
3/31/2023 | 3,951 | 887 | 796 | 921 | N/A |
12/31/2022 | 3,920 | 873 | 738 | 859 | N/A |
9/30/2022 | 3,899 | 838 | 670 | 797 | N/A |
6/30/2022 | 3,865 | 821 | 692 | 814 | N/A |
3/31/2022 | 3,811 | 793 | 739 | 841 | N/A |
12/31/2021 | 3,718 | 769 | 801 | 909 | N/A |
9/30/2021 | 3,619 | 754 | 814 | 919 | N/A |
6/30/2021 | 3,474 | 712 | 778 | 880 | N/A |
3/31/2021 | 3,240 | 654 | 720 | 818 | N/A |
12/31/2020 | 3,085 | 603 | 632 | 725 | N/A |
9/30/2020 | 2,991 | 579 | 592 | 676 | N/A |
6/30/2020 | 2,938 | 547 | 537 | 626 | N/A |
3/31/2020 | 2,978 | 547 | 476 | 570 | N/A |
12/31/2019 | 3,009 | 561 | 506 | 603 | N/A |
9/30/2019 | 2,983 | 550 | 483 | 600 | N/A |
6/30/2019 | 2,964 | 547 | 448 | 574 | N/A |
3/31/2019 | 2,954 | 531 | 452 | 587 | N/A |
12/31/2018 | 2,936 | 513 | 422 | 565 | N/A |
9/30/2018 | 2,896 | 408 | 393 | 532 | N/A |
6/30/2018 | 2,860 | 387 | 387 | 528 | N/A |
3/31/2018 | 2,791 | 377 | 389 | 525 | N/A |
12/31/2017 | 2,725 | 376 | 389 | 516 | N/A |
9/30/2017 | 2,657 | 437 | N/A | 505 | N/A |
6/30/2017 | 2,609 | 433 | N/A | 504 | N/A |
3/31/2017 | 2,563 | 411 | N/A | 487 | N/A |
12/31/2016 | 2,508 | 384 | N/A | 461 | N/A |
9/30/2016 | 2,472 | 370 | N/A | 444 | N/A |
6/30/2016 | 2,426 | 357 | N/A | 425 | N/A |
3/31/2016 | 2,399 | 355 | N/A | 410 | N/A |
12/31/2015 | 2,395 | 353 | N/A | 440 | N/A |
9/30/2015 | 2,419 | 351 | N/A | 431 | N/A |
6/30/2015 | 2,444 | 347 | N/A | 432 | N/A |
3/31/2015 | 2,471 | 343 | N/A | 435 | N/A |
12/31/2014 | 2,486 | 338 | N/A | 419 | N/A |
9/30/2014 | 2,473 | 327 | N/A | 387 | N/A |
6/30/2014 | 2,435 | 317 | N/A | 382 | N/A |
3/31/2014 | 2,405 | 312 | N/A | 365 | N/A |
12/31/2013 | 2,379 | 306 | N/A | 346 | N/A |
9/30/2013 | 2,352 | 301 | N/A | 349 | N/A |
6/30/2013 | 2,339 | 298 | N/A | 330 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0K10's forecast earnings growth (7.7% per year) is above the savings rate (1.8%).
Earnings vs Market: 0K10's earnings (7.7% per year) are forecast to grow slower than the UK market (12.4% per year).
High Growth Earnings: 0K10's earnings are forecast to grow, but not significantly.
Revenue vs Market: 0K10's revenue (3.7% per year) is forecast to grow faster than the UK market (3.4% per year).
High Growth Revenue: 0K10's revenue (3.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 0K10's Return on Equity is forecast to be high in 3 years time